| A15 | Respiratory tuberculosis |
| A15.0 | Tuberculosis of lung |
| A17 | Tuberculosis of nervous system |
| A18 | Tuberculosis of other organs |
| A18.11 | Tuberculosis of kidney and ureter |
| A19 | Miliary tuberculosis |
| A19.0 | Acute miliary tuberculosis of a single specified site |
| A19.1 | Acute miliary tuberculosis of multiple sites |
| A19.2 | Acute miliary tuberculosis, unspecified |
| A19.9 | Miliary tuberculosis, unspecified |
| A31 | Infection due to other mycobacteria |
| B02 | Zoster [herpes zoster] |
| B02.23 | Postherpetic polyneuropathy |
| B15 | Acute hepatitis A |
| B16 | Acute hepatitis B |
| B16.9 | Acute hepatitis B without delta-agent and without hepatic coma |
| B17 | Other acute viral hepatitis |
| B17.0 | Acute delta-(super) infection of hepatitis B carrier |
| B17.8 | Other specified acute viral hepatitis |
| B18 | Chronic viral hepatitis |
| B18.0 | Chronic viral hepatitis B with delta-agent |
| B18.1 | Chronic viral hepatitis B without delta-agent |
| B18.2 | Chronic viral hepatitis C |
| B18.8 | Other chronic viral hepatitis |
| B18.9 | Chronic viral hepatitis, unspecified |
| B19 | Unspecified viral hepatitis |
| B19.0 | Unspecified viral hepatitis with hepatic coma |
| B19.1 | Unspecified viral hepatitis B |
| B19.10 | Unspecified viral hepatitis B without hepatic coma |
| B19.11 | Unspecified viral hepatitis B with hepatic coma |
| B19.9 | Unspecified viral hepatitis without hepatic coma |
| B90 | Sequelae of tuberculosis |
| C22 | Malignant neoplasm of liver and intrahepatic bile ducts |
| C22.0 | Liver cell carcinoma |
| C22.1 | Intrahepatic bile duct carcinoma |
| C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
| C24 | Malignant neoplasm of other and unspecified parts of biliary tract |
| C24.0 | Malignant neoplasm of extrahepatic bile duct |
| C77 | Secondary and unspecified malignant neoplasm of lymph nodes |
| C77.8 | Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions |
| C77.9 | Secondary and unspecified malignant neoplasm of lymph node, unspecified |
| C82 | Follicular lymphoma |
| C82.89 | Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.90 | Follicular lymphoma, unspecified, unspecified site |
| C82.99 | Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83 | Non-follicular lymphoma |
| C83.1 | Mantle cell lymphoma |
| C83.10 | Mantle cell lymphoma, unspecified site |
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 | Mantle cell lymphoma, spleen |
| C83.18 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 | Mantle cell lymphoma, extranodal and solid organ sites |
| C83.3 | Diffuse large B-cell lymphoma |
| C83.30 | Diffuse large B-cell lymphoma, unspecified site |
| C85 | Other specified and unspecified types of non-Hodgkin lymphoma |
| C85.8 | Other specified types of non-Hodgkin lymphoma |
| C85.80 | Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.86 | Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.89 | Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.9 | Non-Hodgkin lymphoma, unspecified |
| C85.90 | Non-Hodgkin lymphoma, unspecified, unspecified site |
| C85.91 | Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C85.92 | Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C85.93 | Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C88 | Malignant immunoproliferative diseases and certain other B-cell lymphomas |
| D13 | Benign neoplasm of other and ill-defined parts of digestive system |
| D13.4 | Benign neoplasm of liver |
| D13.5 | Benign neoplasm of extrahepatic bile ducts |
| D69 | Purpura and other hemorrhagic conditions |
| D69.3 | Immune thrombocytopenic purpura |
| D69.4 | Other primary thrombocytopenia |
| D69.6 | Thrombocytopenia, unspecified |
| D69.8 | Other specified hemorrhagic conditions |
| D89 | Other disorders involving the immune mechanism, not elsewhere classified |
| D89.1 | Cryoglobulinemia |
| E10.41 | Type 1 diabetes mellitus with diabetic mononeuropathy |
| E71.522 | Adrenomyeloneuropathy |
| F11 | Opioid related disorders |
| F11.1 | Opioid abuse |
| F11.10 | Opioid abuse, uncomplicated |
| F11.12 | Opioid abuse with intoxication |
| F11.2 | Opioid dependence |
| F11.20 | Opioid dependence, uncomplicated |
| F11.21 | Opioid dependence, in remission |
| F11.9 | Opioid use, unspecified |
| F11.90 | Opioid use, unspecified, uncomplicated |
| F11.92 | Opioid use, unspecified with intoxication |
| F12 | Cannabis related disorders |
| F12.1 | Cannabis abuse |
| F13 | Sedative, hypnotic, or anxiolytic related disorders |
| F13.1 | Sedative, hypnotic or anxiolytic-related abuse |
| F13.10 | Sedative, hypnotic or anxiolytic abuse, uncomplicated |
| F14 | Cocaine related disorders |
| F14.1 | Cocaine abuse |
| F15 | Other stimulant related disorders |
| F15.1 | Other stimulant abuse |
| F15.10 | Other stimulant abuse, uncomplicated |
| F16 | Hallucinogen related disorders |
| F16.1 | Hallucinogen abuse |
| F17.2 | Nicotine dependence |
| F18 | Inhalant related disorders |
| F18.1 | Inhalant abuse |
| F18.10 | Inhalant abuse, uncomplicated |
| F19 | Other psychoactive substance related disorders |
| F19.1 | Other psychoactive substance abuse |
| F19.10 | Other psychoactive substance abuse, uncomplicated |
| F19.11 | Other psychoactive substance abuse, in remission |
| F19.12 | Other psychoactive substance abuse with intoxication |
| F19.2 | Other psychoactive substance dependence |
| F19.20 | Other psychoactive substance dependence, uncomplicated |
| F19.9 | Other psychoactive substance use, unspecified |
| F55 | Abuse of non-psychoactive substances |
| G58 | Other mononeuropathies |
| G58.9 | Mononeuropathy, unspecified |
| G60 | Hereditary and idiopathic neuropathy |
| G60.0 | Hereditary motor and sensory neuropathy |
| G60.3 | Idiopathic progressive neuropathy |
| G60.8 | Other hereditary and idiopathic neuropathies |
| G61 | Inflammatory polyneuropathy |
| G61.1 | Serum neuropathy |
| G62 | Other and unspecified polyneuropathies |
| G62.9 | Polyneuropathy, unspecified |
| G63 | Polyneuropathy in diseases classified elsewhere |
| G90.0 | Idiopathic peripheral autonomic neuropathy |
| G99 | Other disorders of nervous system in diseases classified elsewhere |
| G99.0 | Autonomic neuropathy in diseases classified elsewhere |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I77 | Other disorders of arteries and arterioles |
| I77.6 | Arteritis, unspecified |
| K65 | Peritonitis |
| K65.1 | Peritoneal abscess |
| K70 | Alcoholic liver disease |
| K70.0 | Alcoholic fatty liver |
| K70.1 | Alcoholic hepatitis |
| K70.10 | Alcoholic hepatitis without ascites |
| K70.11 | Alcoholic hepatitis with ascites |
| K70.9 | Alcoholic liver disease, unspecified |
| K71 | Toxic liver disease |
| K71.3 | Toxic liver disease with chronic persistent hepatitis |
| K71.9 | Toxic liver disease, unspecified |
| K72 | Hepatic failure, not elsewhere classified |
| K72.0 | Acute and subacute hepatic failure |
| K72.00 | Acute and subacute hepatic failure without coma |
| K72.01 | Acute and subacute hepatic failure with coma |
| K72.11 | Chronic hepatic failure with coma |
| K72.90 | Hepatic failure, unspecified without coma |
| K72.91 | Hepatic failure, unspecified with coma |
| K73 | Chronic hepatitis, not elsewhere classified |
| K73.9 | Chronic hepatitis, unspecified |
| K74 | Fibrosis and cirrhosis of liver |
| K74.0 | Hepatic fibrosis |
| K74.6 | Other and unspecified cirrhosis of liver |
| K74.60 | Unspecified cirrhosis of liver |
| K74.69 | Other cirrhosis of liver |
| K75 | Other inflammatory liver diseases |
| K75.0 | Abscess of liver |
| K75.4 | Autoimmune hepatitis |
| K75.81 | Nonalcoholic steatohepatitis (NASH) |
| K76 | Other diseases of liver |
| K76.0 | Fatty (change of) liver, not elsewhere classified |
| K76.1 | Chronic passive congestion of liver |
| K76.2 | Central hemorrhagic necrosis of liver |
| K76.3 | Infarction of liver |
| K76.8 | Other specified diseases of liver |
| K76.89 | Other specified diseases of liver |
| K76.9 | Liver disease, unspecified |
| K77 | Liver disorders in diseases classified elsewhere |
| L93 | Lupus erythematosus |
| L95 | Vasculitis limited to skin, not elsewhere classified |
| M05.2 | Rheumatoid vasculitis with rheumatoid arthritis |
| M05.5 | Rheumatoid polyneuropathy with rheumatoid arthritis |
| M13.0 | Polyarthritis, unspecified |
| M25.48 | Effusion, other site |
| M25.5 | Pain in joint |
| M30 | Polyarteritis nodosa and related conditions |
| M30.0 | Polyarteritis nodosa |
| M30.1 | Polyarteritis with lung involvement [Churg-Strauss] |
| M30.8 | Other conditions related to polyarteritis nodosa |
| M31 | Other necrotizing vasculopathies |
| M31.1 | Thrombotic microangiopathy |
| M31.3 | Wegener's granulomatosis |
| M31.30 | Wegener's granulomatosis without renal involvement |
| M31.31 | Wegener's granulomatosis with renal involvement |
| M31.4 | Aortic arch syndrome [Takayasu] |
| M32 | Systemic lupus erythematosus (SLE) |
| M32.0 | Drug-induced systemic lupus erythematosus |
| N00 | Acute nephritic syndrome |
| N00.3 | Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N00.8 | Acute nephritic syndrome with other morphologic changes |
| N00.9 | Acute nephritic syndrome with unspecified morphologic changes |
| N02 | Recurrent and persistent hematuria |
| N02.8 | Recurrent and persistent hematuria with other morphologic changes |
| N03 | Chronic nephritic syndrome |
| N03.0 | Chronic nephritic syndrome with minor glomerular abnormality |
| N03.2 | Chronic nephritic syndrome with diffuse membranous glomerulonephritis |
| N03.5 | Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N03.7 | Chronic nephritic syndrome with diffuse crescentic glomerulonephritis |
| N03.9 | Chronic nephritic syndrome with unspecified morphologic changes |
| N04 | Nephrotic syndrome |
| N04.8 | Nephrotic syndrome with other morphologic changes |
| N04.9 | Nephrotic syndrome with unspecified morphologic changes |
| N05 | Unspecified nephritic syndrome |
| N05.2 | Unspecified nephritic syndrome with diffuse membranous glomerulonephritis |
| N05.5 | Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N06 | Isolated proteinuria with specified morphological lesion |
| N08 | Glomerular disorders in diseases classified elsewhere |
| N13 | Obstructive and reflux uropathy |
| N18 | Chronic kidney disease (CKD) |
| N18.6 | End stage renal disease |
| N18.9 | Chronic kidney disease, unspecified |
| N23 | Unspecified renal colic |
| N26 | Unspecified contracted kidney |
| N26.9 | Renal sclerosis, unspecified |
| N98.3 | Complications of attempted introduction of embryo in embryo transfer |
| O09 | Supervision of high risk pregnancy |
| O09.3 | Supervision of pregnancy with insufficient antenatal care |
| O12 | Gestational [pregnancy-induced] edema and proteinuria without hypertension |
| O26 | Maternal care for other conditions predominantly related to pregnancy |
| O28 | Abnormal findings on antenatal screening of mother |
| O28.9 | Unspecified abnormal findings on antenatal screening of mother |
| O36.01 | Maternal care for anti-D [Rh] antibodies |
| O99.01 | Anemia complicating pregnancy |
| O99.280 | Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester |
| P58 | Neonatal jaundice due to other excessive hemolysis |
| P59 | Neonatal jaundice from other and unspecified causes |
| P59.0 | Neonatal jaundice associated with preterm delivery |
| P59.9 | Neonatal jaundice, unspecified |
| R05 | Cough |
| R16 | Hepatomegaly and splenomegaly, not elsewhere classified |
| R17 | Unspecified jaundice |
| R18 | Ascites |
| R18.8 | Other ascites |
| R19 | Other symptoms and signs involving the digestive system and abdomen |
| R19.0 | Intra-abdominal and pelvic swelling, mass and lump |
| R43.0 | Anosmia |
| R74.0 | Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] |
| R77 | Other abnormalities of plasma proteins |
| R78 | Findings of drugs and other substances, not normally found in blood |
| R78.1 | Finding of opiate drug in blood |
| R78.2 | Finding of cocaine in blood |
| R78.4 | Finding of other drugs of addictive potential in blood |
| R78.5 | Finding of other psychotropic drug in blood |
| R80 | Proteinuria |
| R94 | Abnormal results of function studies |
| R94.4 | Abnormal results of kidney function studies |
| R94.5 | Abnormal results of liver function studies |
| T39 | Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics |
| T39.013 | Poisoning by aspirin, assault |
| T39.094S | Poisoning by salicylates, undetermined, sequela |
| T39.1 | Poisoning by, adverse effect of and underdosing of 4-Aminophenol derivatives |
| T39.1X1 | Poisoning by 4-Aminophenol derivatives, accidental (unintentional) |
| T39.1X2 | Poisoning by 4-Aminophenol derivatives, intentional self-harm |
| T39.1X3 | Poisoning by 4-Aminophenol derivatives, assault |
| T39.1X4 | Poisoning by 4-Aminophenol derivatives, undetermined |
| T40 | Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens] |
| T40.2X5 | Adverse effect of other opioids |
| T42.4X5A | Adverse effect of benzodiazepines, initial encounter |
| T86 | Complications of transplanted organs and tissue |
| T86.4 | Complications of liver transplant |
| T86.40 | Unspecified complication of liver transplant |
| T86.41 | Liver transplant rejection |
| T86.42 | Liver transplant failure |
| T86.43 | Liver transplant infection |
| T86.49 | Other complications of liver transplant |
| Z00 | Encounter for general examination without complaint, suspected or reported diagnosis |
| Z00.0 | Encounter for general adult medical examination |
| Z00.00 | Encounter for general adult medical examination without abnormal findings |
| Z00.01 | Encounter for general adult medical examination with abnormal findings |
| Z00.8 | Encounter for other general examination |
| Z01.41 | Encounter for routine gynecological examination |
| Z01.411 | Encounter for gynecological examination (general) (routine) with abnormal findings |
| Z01.83 | Encounter for blood typing |
| Z01.84 | Encounter for antibody response examination |
| Z02 | Encounter for administrative examination |
| Z04 | Encounter for examination and observation for other reasons |
| Z11.1 | Encounter for screening for respiratory tuberculosis |
| Z11.5 | Encounter for screening for other viral diseases |
| Z11.59 | Encounter for screening for other viral diseases |
| Z12.10 | Encounter for screening for malignant neoplasm of intestinal tract, unspecified |
| Z13.1 | Encounter for screening for diabetes mellitus |
| Z13.220 | Encounter for screening for lipoid disorders |
| Z13.6 | Encounter for screening for cardiovascular disorders |
| Z16 | Resistance to antimicrobial drugs |
| Z20 | Contact with and (suspected) exposure to communicable diseases |
| Z20.5 | Contact with and (suspected) exposure to viral hepatitis |
| Z22.50 | |
| Z22.59 | |
| Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
| Z30.8 | Encounter for other contraceptive management |
| Z32.0 | Encounter for pregnancy test |
| Z33 | Pregnant state |
| Z34 | Encounter for supervision of normal pregnancy |
| Z34.0 | Encounter for supervision of normal first pregnancy |
| Z34.8 | Encounter for supervision of other normal pregnancy |
| Z34.9 | Encounter for supervision of normal pregnancy, unspecified |
| Z34.90 | Encounter for supervision of normal pregnancy, unspecified, unspecified trimester |
| Z36 | Encounter for antenatal screening of mother |
| Z36.0 | Encounter for antenatal screening for chromosomal anomalies |
| Z36.8 | Encounter for other antenatal screening |
| Z48.23 | Encounter for aftercare following liver transplant |
| Z51.81 | Encounter for therapeutic drug level monitoring |
| Z67 | Blood type |
| Z68 | Body mass index [BMI] |
| Z71.5 | Drug abuse counseling and surveillance |
| Z71.51 | Drug abuse counseling and surveillance of drug abuser |
| Z71.52 | Counseling for family member of drug abuser |
| Z77 | Other contact with and (suspected) exposures hazardous to health |
| Z77.120 | Contact with and (suspected) exposure to mold (toxic) |
| Z79 | Long term (current) drug therapy |
| Z79.1 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
| Z79.52 | Long term (current) use of systemic steroids |
| Z79.89 | Other long term (current) drug therapy |
| Z79.890 | Hormone replacement therapy |
| Z79.891 | Long term (current) use of opiate analgesic |
| Z79.899 | Other long term (current) drug therapy |
| Z84 | Family history of other conditions |
| Z85 | Personal history of malignant neoplasm |
| Z85.05 | Personal history of malignant neoplasm of liver |
| Z85.09 | Personal history of malignant neoplasm of other digestive organs |
| Z85.72 | Personal history of non-Hodgkin lymphomas |
| Z86.11 | Personal history of tuberculosis |
| Z94.4 | Liver transplant status |